John Charles Thomas sold $347K of Krystal Biotech, Inc. (KRYS) stock

John Charles Thomas, EVP, General Counsel of Krystal Biotech, Inc. (KRYS), sold 1,000 shares of KRYS stock worth $347K, per an SEC Form 4 filed Jun 26, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jun 25, 2026, 1 day before it was made public.

KRYS has moved -7.2% since the trade date, from $359.93 to $333.85 (Sep 21, 2026 close).